A message from Dr. Fearon
I am pleased to share that Sarah Hawley, Ph.D., M.P.H., will serve as associate director for training, education and career development for the Rogel Cancer Center.
In addition, we have added two new assistant director roles to our education and training program to provide additional support to these efforts and bring varied perspectives representing the continuum of cancer research. Goutham Narla, M.D., Ph.D., and N. Lynn Henry, M.D., Ph.D., will serve as assistant directors.
Dr. Hawley is professor of general medicine, health management and policy, and health behavior and health education at the Medical School and School of Public Health.
She has served on numerous education and training committees and has provided outstanding mentorship and support to junior faculty. Her long-standing commitment and passion in this area will bring new ideas and bolster existing efforts to develop the next generation of cancer pioneers.
In her research, Dr. Hawley focuses on evaluating and improving patient-centered cancer care across the continuum from screening through treatment and into survivorship, with a focus on vulnerable populations. She is the co-leader of our health behavior and outcomes research program and co-director of the Center for Health Communications Research shared resource.
Dr. Narla is professor and division chief of genetic medicine and professor of human genetics at Michigan Medicine. He has held several leadership positions in his career, including roles focused on education and training. His research interests include furthering insights into the genetic and cellular mechanisms driving human cancer development and progression and developing new therapeutic approaches for cancer.
Dr. Henry is associate professor of hematology/oncology and the breast oncology disease lead. An active clinical researcher, she focuses on personalizing treatment for breast cancer, including ways to manage symptoms and side effects of cancer and its treatment.
Working with Dr. Narla and Dr. Henry, Dr. Hawley will build upon the successful programs and initiatives put in place by Beth Lawlor, M.D., Ph.D., who left the university in June. This will include outreach to high school students interested in science, support for a broad collection of undergraduate, graduate, and post-graduate trainees, and programs to develop the careers of junior faculty. In addition, Dr. Hawley is interested in supporting associate professors and professors in their efforts to mentor others.
Dr. Hawley will serve on the Rogel Cancer Center’s senior leadership council. Dr. Narla and Dr. Henry will join the executive committee. The appointments are effective March 1.
We are excited to expand our resources and commitment in the area of training, education and career development and look forward to the enhanced opportunities these new leaders will bring to our faculty, trainees and community. Please join me in congratulating Drs. Hawley, Narla and Henry.
Sincerely,
Eric R. Fearon, M.D., Ph.D.
Emanuel N. Maisel Professor of Oncology
Director, University of Michigan Rogel Cancer Center
Goutham Narla, M.D., Ph.D.
Professor of Internal Medicine
Chief, Division of Genetic Medicine